| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |